Guosheng Feng
ORCID：0000-0002-3975-4032
发表论文 65 篇 · 总被引 2744 次 · h-index 23
代表论文
- Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer (2022 · JAMA · 被引 497)
- Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer (2021 · JAMA Oncology · 被引 410)
- Tn antigen promotes human colorectal cancer metastasis via H‐Ras mediated epithelial‐mesenchymal transition activation (2019 · Journal of Cellular and Molecular Medicine · 被引 75)
- Biosimilar candidate IBI305 plus paclitaxel/carboplatin for the treatment of non-squamous non-small cell lung cancer (2019 · Translational Lung Cancer Research · 被引 36)
- A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506) (2017 · BMC Cancer · 被引 30)
- Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (2017 · Oncotarget · 被引 26)